Published in J Nucl Cardiol on August 04, 2008
Atherosclerosis across 4000 years of human history: the Horus study of four ancient populations. Lancet (2013) 5.61
Systemic administration of optimized aptamer-siRNA chimeras promotes regression of PSMA-expressing tumors. Nat Biotechnol (2009) 3.78
Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study. J Am Coll Cardiol (2010) 3.21
Regadenoson induces comparable left ventricular perfusion defects as adenosine: a quantitative analysis from the ADVANCE MPI 2 trial. JACC Cardiovasc Imaging (2009) 1.92
Atherosclerosis in ancient Egyptian mummies: the Horus study. JACC Cardiovasc Imaging (2011) 1.83
Assessing the need for nuclear cardiology and other advanced cardiac imaging modalities in the developing world. J Nucl Cardiol (2009) 1.73
Computed tomographic assessment of atherosclerosis in ancient Egyptian mummies. JAMA (2009) 1.67
Selective improvement in Seattle Heart Failure Model risk stratification using iodine-123 meta-iodobenzylguanidine imaging. J Nucl Cardiol (2012) 1.51
Regadenoson provides perfusion results comparable to adenosine in heterogeneous patient populations: a quantitative analysis from the ADVANCE MPI trials. J Nucl Cardiol (2014) 1.45
Rational truncation of an RNA aptamer to prostate-specific membrane antigen using computational structural modeling. Nucleic Acid Ther (2011) 1.16
TRAF2 phosphorylation modulates tumor necrosis factor alpha-induced gene expression and cell resistance to apoptosis. Mol Cell Biol (2008) 1.00
The E8--E2 gene product of human papillomavirus type 16 represses early transcription and replication but is dispensable for viral plasmid persistence in keratinocytes. J Virol (2008) 0.99
TRAF2 suppresses basal IKK activity in resting cells and TNFalpha can activate IKK in TRAF2 and TRAF5 double knockout cells. J Mol Biol (2009) 0.90
Biological and analytical stability of a peripheral blood gene expression score for obstructive coronary artery disease in the PREDICT and COMPASS studies. J Cardiovasc Transl Res (2014) 0.88
Regadenoson pharmacologic stress for myocardial perfusion imaging: a three-way comparison between regadenoson administered at peak exercise, during walk recovery, or no-exercise. J Nucl Cardiol (2012) 0.83
Effects of vorapaxar on platelet reactivity and biomarker expression in non-ST-elevation acute coronary syndromes. The TRACER Pharmacodynamic Substudy. Thromb Haemost (2014) 0.80
The time and place for appropriate radionuclide imaging: now and everywhere. J Nucl Cardiol (2011) 0.79
President's message: The global burden of cardiovascular disease. J Nucl Cardiol (2007) 0.79
Pharmacologic stress myocardial perfusion imaging: a practical approach. J Nucl Cardiol (2007) 0.77
Something old, something new--computed tomography studies of the cardiovascular system in ancient Egyptian mummies. Am Heart Hosp J (2010) 0.77
Atherosclerotic cardiovascular disease in Egyptian women: 1570 BCE-2011 CE. Int J Cardiol (2012) 0.76
Clinical imaging for prevention: directed strategies for improved detection of presymptomatic patients with undetected atherosclerosis--Part I: Clinical imaging for prevention. J Nucl Cardiol (2008) 0.75
Potential indications for coronary angiography by computed tomography. Am Heart Hosp J (2005) 0.75
Atherosclerosis in ancient populations - Authors' reply. Lancet (2013) 0.75
Is a revision of the "nuclear cardiology warranty" in order? J Nucl Cardiol (2003) 0.75
What to do with an equivocal myocardial perfusion study? J Nucl Cardiol (2009) 0.75
Coronary computed tomographic angiography: competitive or complementary? J Nucl Cardiol (2006) 0.75
Regadenoson and exercise myocardial perfusion imaging: the courtship continues. J Nucl Cardiol (2013) 0.75
Virtual colonoscopy to screen for colorectal cancer. N Engl J Med (2004) 0.75
Advanced hybrid stress testing: a potential new paradigm combining exercise and pharmacologic stress. J Nucl Cardiol (2012) 0.75
iPhone apps for heterozygous familial hypercholesterolemia. J Clin Lipidol (2013) 0.75
Myocardial perfusion imaging in hypertrophic cardiomyopathy. Am Heart Hosp J (2010) 0.75
Delayed heart rate recovery after adenosine stress testing with supplemental arm exercise predicts mortality. J Nucl Cardiol (2009) 0.75
Minimally Invasive Aortic Valve Replacement via Right Anterior Minithoracotomy and Central Aortic Cannulation: A 13-Year Experience. Innovations (Phila) (2017) 0.75
Indications and reimbursement of cardiac computed tomography angiography: history, present and future perspectives. J Cardiovasc Comput Tomogr (2007) 0.75
Role of computed tomography and perfusion imaging in patients with known or suspected coronary artery disease. J Nucl Cardiol (2006) 0.75
Highlights of the 2007 scientific sessions of the American Society of Nuclear Cardiology San Diego, California, September 6-9, 2007. J Am Coll Cardiol (2007) 0.75
Morbid obesity and myocardial perfusion imaging. Am Heart Hosp J (2007) 0.75
Challenges and strategies in the provision of high-quality nuclear cardiology imaging services in office-based cardiology practice. J Nucl Cardiol (2004) 0.75
An example of the clinical selectivity of regadenoson for the A2a adenosine receptor. Am Heart Hosp J (2009) 0.75